atorvastatin has been researched along with Long QT Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, L; Fang, Q; Feng, P; Guo, F; Li, B; Liang, Z; Xu, X; Zhan, G; Zhang, B; Zhao, L | 1 |
| Corti, N; Hoppe, L; Kovari, H; Maechler, S; Niedrig, D; Russmann, S | 1 |
| Cui, W; Liu, F; Lu, JC; Pei, WN; Xie, RQ; Yang, C | 1 |
1 trial(s) available for atorvastatin and Long QT Syndrome
| Article | Year |
|---|---|
Statin therapy shortens QTc, QTcd, and improves cardiac function in patients with chronic heart failure.
Topics: Atorvastatin; Chronic Disease; Electrocardiography; Heart Failure; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Long QT Syndrome; Pyrroles; Treatment Outcome; Ventricular Function, Left | 2010 |
2 other study(ies) available for atorvastatin and Long QT Syndrome
| Article | Year |
|---|---|
The enhancement of cardiotoxicity that results from inhibiton of CYP 3A4 activity and hERG channel by berberine in combination with statins.
Topics: Action Potentials; Animals; Atorvastatin; Berberine; Cytochrome P-450 CYP3A; ERG1 Potassium Channel; Gene Expression; HEK293 Cells; Hep G2 Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kinetics; Long QT Syndrome; Microsomes, Liver; Rats; Simvastatin; Testosterone | 2018 |
Drug safety of macrolide and quinolone antibiotics in a tertiary care hospital: administration of interacting co-medication and QT prolongation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Atorvastatin; Clonidine; Drug Interactions; Drug Therapy, Combination; Electrocardiography; Female; Humans; Long QT Syndrome; Macrolides; Male; Medication Errors; Middle Aged; Quinolones; Risk Factors; Simvastatin; Tertiary Care Centers; Torsades de Pointes; Young Adult | 2016 |